Cargando…
Diacerein ameliorates acetaminophen hepatotoxicity in rats via inhibiting HMGB1/TLR4/NF-κB and upregulating PPAR-γ signal
BACKGROUND: Acetaminophen (APAP) is a worldwide antipyretic as well as an analgesic medication. It has been extensively utilized during the outbreak of coronavirus 2019 (COVID-19). APAP misuse would lead to liver injury. Diacerein (DIA), an anthraquinone derivative, has antioxidant and inflammatory...
Autores principales: | Mohamed Kamel, Gellan Alaa, Harahsheh, Eman, Hussein, Shaimaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975726/ https://www.ncbi.nlm.nih.gov/pubmed/35366176 http://dx.doi.org/10.1007/s11033-022-07366-5 |
Ejemplares similares
-
HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity
por: Yang, Runkuan, et al.
Publicado: (2014) -
Diacerein counteracts acetaminophen-induced hepatotoxicity in mice via targeting NLRP3/caspase-1/IL-1β and IL-4/MCP-1 signaling pathways
por: Elshal, Mahmoud, et al.
Publicado: (2022) -
Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity
por: Zillen, Daan, et al.
Publicado: (2021) -
Erratum to: 18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation
por: Mahmoud, Ayman M., et al.
Publicado: (2016) -
Mitochondrial–Lysosomal Axis in Acetaminophen Hepatotoxicity
por: Moles, Anna, et al.
Publicado: (2018)